Posterity Health, a telemedicine startup providing personalized male fertility advice, treatments, and educational resources, raised $7.5 million in a new equity funding round.
Distributed Ventures, an early-stage venture capital firm, led the investment round with participation from FCA Venture Partners and WVV Capital.
With new funds, Posterity Health plans to further develop its technology-enabled male fertility services, including at-home diagnostics, virtual visits, and in-person consults focused on improving a man’s fertility status. The company seeks to educate, engage, and treat men, shifting the burden of conceiving from solely the woman and creating a unifying experience for the couple.
According to WHO, infertility is a global health issue affecting millions of people of reproductive age worldwide. Available data suggests that between 48 million couples and 186 million individuals have infertility globally.
Commenting on the funding news announcement, Pam Pure, CEO of Posterity Health, said: “This funding allows us to move one step closer to achieving our mission to provide access to male fertility care for every couple trying to conceive.” “Male fertility specialists are scarce resources with approximately 200 fellowship-trained physicians in the country. In addition, males prefer evaluation and treatment from home. The expanded Posterity Health network will double the number of reproductive urologists using the platform and provide easy access to in-person care when required.”
Including the latest round, Posterity Health has received more than $14 million in funding to date. The startup previously secured $6 million in seed funding in July 2022 from Distributed Ventures.
“There is an increasing demand for the services and expertise that are unique to Posterity Health, making Distributed Ventures’ funding a crucial component of our goal to provide support for nascent healthtech companies. We’re proud to support Posterity Health’s mission to make male fertility care more accessible while ending the stigma surrounding it at an imperative time when these services are in high demand,” said Shawn Ellis, Managing Partner at Distributed Ventures. “By leading an investment in Posterity Health, we are investing in the digital transformation technologies that are crucial for increasing access to innovative and comprehensive healthcare.”
Telehealth and telemedicine funding
According to our funding database, telemedicine companies providing fertility care have raised nearly $2 billion in venture capital funding to date.
The latest funding round in fertility care includes:
Turtle Health, an online fertility counseling clinic, raised $5 million in Seed funding from Switch Ventures, Blue Seed Collective, NextGen Venture Partners, Mayo Clinic Ventures, and US Fertility, the parent company of IVF clinic Shady Grove.
Apricity, a telemedicine startup providing fertility care, secured $17 million in Series B funding. MTIP, the Swiss health tech investor, led the investment round with participation from Barcelona-based specialist consumer fund Iris Ventures.
Mojocare, a Bangalore-based telemedicine providing fertility and haircare, raised $20 million in Series A funding led by B Capital with participation from other investors.
Click here to read more about the latest digital health funding news…